Planned phase I trial of AQP 182 for multi-drug resistant bacterial infections.
Latest Information Update: 09 Aug 2012
Price :
$35 *
At a glance
- Drugs AQP 182 (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 09 Aug 2012 New trial record